Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China’s National Medical Products Administration3 January 2025
Olin Corporation Stock: Shares Are Cheap Even With Subdued Results (Upgrade) (NYSE:OLN)3 January 2025
Six-Figure Prices for Bitcoin Rock Ordinals and EtherRock NFTs Reignite Hopes for Return of NFT Mania